These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3534114)

  • 21. C1-Inh and heparan sulfate can prevent discordant rejection.
    Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
    Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
    [No Abstract]   [Full Text] [Related]  

  • 22. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts.
    Rose AG; Cooper DK; Human PA; Reichenspurner H; Reichart B
    J Heart Lung Transplant; 1991; 10(2):223-34. PubMed ID: 2031919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immune reaction in hyperacute rejection.
    Wada S; Ochikubo H; Sugawara Y; Sueda T; Fujii K; Kajihara H; Matsuura Y
    Transplant Proc; 1998 Nov; 30(7):3818-20. PubMed ID: 9838672
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor.
    Kemp E; Steinbrüchel D; Starklint H; Larsen S; Henriksen I; Dieperink H
    Transplant Proc; 1987 Dec; 19(6):4471-4. PubMed ID: 2827356
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
    Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
    Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of new immunosuppressant and experimental cardiac transplantation].
    Ochiai T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1961-8. PubMed ID: 2236608
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of complement suppression on xenograft survival in hyperacute rejection.
    Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
    Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation of heart xenograft survival in the rat: effectiveness of cyclosporine in preventing early xenoantibody rebound after membrane plasmapheresis.
    Van de Stadt J; Meriggi F; Vendeville B; Weill B; Crougneau S; Filipponi F; Michel A; Houssin D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):543-5. PubMed ID: 2650197
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rejection of discordant xenografts of the liver and heart].
    Settaf A; Meriggi F; Gane P; Capron-Laudereau M; Reynes M; Rouger P; Houssin D; Bismuth H
    J Chir (Paris); 1989; 126(6-7):365-9. PubMed ID: 2674170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on FK506 in experimental organ transplantation.
    Ochiai T; Sakamoto K; Nagata M; Nakajima K; Goto T; Hori S; Kenmochi T; Nakagori T; Asano T; Isono K
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):209-14. PubMed ID: 2450414
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed rejection of liver xenografts compared to heart xenografts in the rat.
    Settaf A; Meriggi F; Van de Stadt J; Gane P; Crougneau S; Reynes M; Rouger P; Houssin D
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1155-7. PubMed ID: 3274299
    [No Abstract]   [Full Text] [Related]  

  • 32. The mechanism of discordant xenograft rejection.
    Miyagawa S; Hirose H; Shirakura R; Nakata S; Naka Y; Kitagawa S; Nakano S; Matsumoto M; Seya T; Kitamura H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):520-1. PubMed ID: 2650190
    [No Abstract]   [Full Text] [Related]  

  • 33. The different influences of allosensitization and xenosensitization on cellular rejection.
    Fryer JP; Chen S; Johnson EM; Sun LH; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):674. PubMed ID: 8623338
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients.
    Jakobs FM; Davis EA; White T; Sanfilippo F; Baldwin WM
    J Heart Lung Transplant; 1998 Mar; 17(3):306-11. PubMed ID: 9563608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection.
    Wang H; DeVries ME; Deng S; Khandaker MH; Pickering JG; Chow LH; Garcia B; Kelvin DJ; Zhong R
    Nat Med; 2000 May; 6(5):549-55. PubMed ID: 10802711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterotopic heart transplantation in the rat.
    Zisbrod Z; Racelis D; Schanzer H
    Mt Sinai J Med; 1981; 48(5):455-8. PubMed ID: 7029252
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
    Magee JC; Collins BH; Harland RC; Bollinger RR; Frank MM; Platt JL
    Transplant Proc; 1995 Feb; 27(1):271. PubMed ID: 7878999
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of FC43 emulsion against hyperacute rejection in rodent discordant xenotransplantation.
    Wada S; Kajihara H; Murakami H; Sueda T; Matsuura Y
    J Heart Lung Transplant; 1995; 14(5):968-72. PubMed ID: 8800735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival.
    Davis EA; Lam TT; Qian Z; Ibrahim S; Baldwin WM; Sanfilippo FP
    J Heart Lung Transplant; 1995; 14(5):973-80. PubMed ID: 8800736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection.
    Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
    Transplant Proc; 1992 Apr; 24(2):477-8. PubMed ID: 1566394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.